Literature DB >> 21957198

A biochemical fluorometric method for assessing the oxidative properties of HDL.

Theodoros Kelesidis1, Judith S Currier2, Diana Huynh2, David Meriwether3, Christina Charles-Schoeman2, Srinivasa T Reddy4, Alan M Fogelman2, Mohamad Navab2, Otto O Yang5.   

Abstract

Most current assays of HDL functional properties are cell-based. We have developed a fluorometric biochemical assay based on the oxidation of dihydrorhodamine 123 (DHR) by HDL. This cell-free assay assesses the intrinsic ability of HDL to be oxidized by measuring increasing fluorescence due to DHR oxidation over time. The assay distinguishes the oxidative potential of HDL taken from different persons, and the results are reproducible. Direct comparison of this measurement correlated well with results obtained using a validated cell-based assay (r(2) = 0.62, P < 0.001). The assay can be scaled from a 96-well format to a 384-well format and, therefore, is suitable for high-throughput implementation. This new fluorometric method offers an inexpensive, accurate, and rapid means for determining the oxidative properties of HDL that is applicable to large-scale clinical studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21957198      PMCID: PMC3220300          DOI: 10.1194/jlr.D018937

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  43 in total

1.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

2.  D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice.

Authors:  Mohamad Navab; G M Anantharamaiah; Susan Hama; Greg Hough; Srinivasa T Reddy; Joy S Frank; David W Garber; Shaila Handattu; Alan M Fogelman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-04-21       Impact factor: 8.311

Review 3.  Detection of reactive nitrogen species using 2,7-dichlorodihydrofluorescein and dihydrorhodamine 123.

Authors:  H Ischiropoulos; A Gow; S R Thom; N W Kooy; J A Royall; J P Crow
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

4.  Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.

Authors:  A D Watson; J A Berliner; S Y Hama; B N La Du; K F Faull; A M Fogelman; M Navab
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

5.  Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence.

Authors:  W Sattler; D Mohr; R Stocker
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

6.  Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII.

Authors:  B Garner; A R Waldeck; P K Witting; K A Rye; R Stocker
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

7.  Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol.

Authors:  B Garner; P K Witting; A R Waldeck; J K Christison; M Raftery; R Stocker
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

8.  Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits.

Authors:  Brian J Van Lenten; Alan C Wagner; Mohamad Navab; G M Anantharamaiah; Susan Hama; Srinivasa T Reddy; Alan M Fogelman
Journal:  J Lipid Res       Date:  2007-08-10       Impact factor: 5.922

9.  Peroxynitrite-mediated oxidation of dihydrorhodamine 123.

Authors:  N W Kooy; J A Royall; H Ischiropoulos; J S Beckman
Journal:  Free Radic Biol Med       Date:  1994-02       Impact factor: 7.376

Review 10.  HDL as a biomarker, potential therapeutic target, and therapy.

Authors:  Mohamad Navab; G M Anantharamaiah; Srinivasa T Reddy; Brian J Van Lenten; Alan M Fogelman
Journal:  Diabetes       Date:  2009-12       Impact factor: 9.461

View more
  34 in total

1.  Dialysis Modalities and HDL Composition and Function.

Authors:  Michael Holzer; Gernot Schilcher; Sanja Curcic; Markus Trieb; Senka Ljubojevic; Tatjana Stojakovic; Hubert Scharnagl; Chantal M Kopecky; Alexander R Rosenkranz; Akos Heinemann; Gunther Marsche
Journal:  J Am Soc Nephrol       Date:  2015-03-05       Impact factor: 10.121

2.  Psoriasis alters HDL composition and cholesterol efflux capacity.

Authors:  Michael Holzer; Peter Wolf; Sanja Curcic; Ruth Birner-Gruenberger; Wolfgang Weger; Martin Inzinger; Dalia El-Gamal; Christian Wadsack; Akos Heinemann; Gunther Marsche
Journal:  J Lipid Res       Date:  2012-05-30       Impact factor: 5.922

3.  Pleiotropic effects of apolipoprotein C3 on HDL functionality and adipose tissue metabolic activity.

Authors:  Evangelia Zvintzou; Marie Lhomme; Stella Chasapi; Serafoula Filou; Vassilis Theodoropoulos; Eva Xapapadaki; Anatol Kontush; George Spyroulias; Constantinos C Tellis; Alexandros D Tselepis; Caterina Constantinou; Kyriakos E Kypreos
Journal:  J Lipid Res       Date:  2017-07-12       Impact factor: 5.922

4.  Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection.

Authors:  Theodoros Kelesidis; Nicholas Jackson; Grace A McComsey; Xiaoyan Wang; David Elashoff; Michael P Dube; Todd T Brown; Otto O Yang; James H Stein; Judith S Currier
Journal:  AIDS       Date:  2016-11-13       Impact factor: 4.177

5.  Association between cholesterol efflux capacity and coronary restenosis after successful stent implantation.

Authors:  Satoshi Imaizumi; Shin-Ichiro Miura; Kohei Takata; Yosuke Takamiya; Takashi Kuwano; Makoto Sugihara; Amane Ike; Atsushi Iwata; Hiroaki Nishikawa; Keijiro Saku
Journal:  Heart Vessels       Date:  2015-09-04       Impact factor: 2.037

Review 6.  High-density lipoprotein function in rheumatoid arthritis.

Authors:  Michelle J Ormseth; C Michael Stein
Journal:  Curr Opin Lipidol       Date:  2016-02       Impact factor: 4.776

7.  Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein.

Authors:  Shubhendu Sen Roy; Huy Cong Xuan Nguyen; Thomas A Angelovich; Anna C Hearps; Diana Huynh; Anthony Jaworowski; Theodoros Kelesidis
Journal:  J Vis Exp       Date:  2017-10-12       Impact factor: 1.355

Review 8.  Molecules that mimic apolipoprotein A-I: potential agents for treating atherosclerosis.

Authors:  Luke J Leman; Bruce E Maryanoff; M Reza Ghadiri
Journal:  J Med Chem       Date:  2013-10-29       Impact factor: 7.446

9.  Human T lymphotropic virus type 1 and risk of cardiovascular disease: High-density lipoprotein dysfunction versus serum HDL-C concentrations.

Authors:  Sara Samadi; Samaneh Abolbashari; Zahra Meshkat; Amir Hooshang Mohammadpour; Theodoros Kelesidis; Aida Gholoobi; Mehrane Mehramiz; Mahla Tabadkani; Fatemeh Sadabadi; Razieh Dalirfardouei; Gordon A Ferns; Majid Ghayour-Mobarhan; Amir Avan
Journal:  Biofactors       Date:  2019-01-29       Impact factor: 6.113

10.  High-density lipoprotein lipid peroxidation as a molecular signature of the risk for developing cardiovascular disease: Results from MASHAD cohort.

Authors:  Sara Samadi; Mehrane Mehramiz; Theodoros Kelesidis; Majid Ghayour Mobarhan; Amir Hosein Sahebkar; Habibollah Esmaily; Mohsen Moohebati; Zahra Farjami; Gordon A Ferns; Amir Hooshang Mohammadpour; Amir Avan
Journal:  J Cell Physiol       Date:  2019-02-19       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.